Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT06890468
Eligibility Criteria:
Inclusion Criteria:
* Ageā„18 \<100years
* Head and neck artery stenosis/occlusion, moyamoya disease, aneurysm, artery dissection, etc., may include patients with acute stroke, chronic cerebral ischemia, and asymptomatic patients. After clinical assessment, CT perfusion imaging is required
* The image quality meets the requirements of diagnosis and post-processing
* Patients who follow the scanning strategy to complete the examination
* The patient or his or her family agrees to provide clinical data and follow-up
* Patients or their families sign informed consent forms
Exclusion Criteria:
* \< 18 years old
* People who are allergic to iodine contrast agents, or who cannot be tested temporarily due to taking metformin or aminoglycoside drugs
* Renal failure patient
* Severe cardiac insufficiency
* Severe liver damage
* Patients with an expected survival of less than 1 year
* Patients with cerebrovascular diseasePregnant woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT06890468
Study Brief:
Protocol Section:
NCT06890468